Climb Bio, Inc. (CLYM) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $160.47M | -24.3% |
| 2024 | $211.88M | +96.9% |
| 2023 | $107.60M | -16.4% |
| 2022 | $128.72M | -23.0% |
| 2021 | $167.20M | +769.3% |
| 2020 | -$24.98M | -349.2% |
| 2019 | -$5.56M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $160.47M | -24.3% |
| 2024 | $211.88M | +96.9% |
| 2023 | $107.60M | -16.4% |
| 2022 | $128.72M | -23.0% |
| 2021 | $167.20M | +769.3% |
| 2020 | -$24.98M | -349.2% |
| 2019 | -$5.56M | — |